You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on DrugBank.

This drug entry is a stub and has not been fully annotated. It was added on November 30, 2015 and is scheduled to be annotated soon.

NameMagnesium carbonate
Accession NumberDB09481
TypeSmall Molecule
GroupsApproved
DescriptionNot Available
IndicationNot Available
Structure
Thumb
SynonymsNot Available
Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Cepasium Tab 100mgTablet100 mgOralLaboratoires Cortunon Inc.1979-12-312002-08-23Canada
Humco Dewees CarminativeSuspension50 mg/mLOralHumco Holding Group. Inc.1998-03-25Not applicableUs
International BrandsNot Available
Brand mixtures
NameLabellerIngredients
Acid Gone AntacidMajor
Acid Gone Antacid Extra StrengthMajor
Aluminum Hydroxide and Magnesium CarbonateSimpex Pharma Pvt. Ltd
AntacidMeijer Distribution
Antacid - TabSwiss Herbal Remedies Ltd.
Antacid Extra StrengthRite Aid
Aspirin Plus Stomach Guard Ext.stgth.capletSterling Winthrop Inc.
Aspirin Plus Stomach Guard Extra StrengthBayer Inc Consumer Care
Aspirin Plus Stomach Guard TabSterling Winthrop Inc.
Aspirin With Stomach GuardBayer Inc Consumer Care
Aspirin With Stomach Guard Extra Strength - TabBayer Inc Consumer Care
Calcium and Magnesium TabCountry Health Laboratories Ltd.
Cvs Health Extra Strength Heartburn Relief Antacid Original FlavorCvs Health
Equate Antacid Extra StrengthWalmart Stores
Equate Extra Strength AntacidWalmart Stores
EstomarolLaboratorios Imperiales, S.A. De C.V.
Foamcoat AntacidGuardian Drug Company
Gavis-care AntacidGericare Pharmaceuticals
GavisconGlaxo Smith Kline Consumer Healthcare Holdings (Us) Llc
Gaviscon Extra StrengthGlaxo Smith Kline Consumer Heathcare Lp
Good Neighbor Pharmacy Antacid Extra StrengthAmerisource Bergen
InonSato Pharmaceutical
Leader Antacid Extra StrengthCardinal Health
Maalox Antacid CapletsRhone Poulenc Rorer
Magnebind 400 RxNephro Tech, Inc.
Magnesium Comprime TabHerbes Universelles Inc.
RenacidinUnited Guardian, Inc.
Riginic Antacid LiquidRij Pharmaceutical Corporation
Rx Act Antacid Extra StrengthH.E.B.
Sohmed Acid ReducerSOHM Inc.
Stomachin AntacidChang Kuo Chou Pharmaceutical Co. Ltd.
Sunmark Antacid Extra StrengthMc Kesson
Tri-buffered Asa TabZee Medical Inc
SaltsNot Available
CAS numberNot Available
WeightNot Available
Chemical FormulaNot Available
InChI KeyNot Available
InChINot Available
IUPAC NameNot Available
SMILESNot Available
Drug Interactions
Drug
16-BromoepiandrosteroneThe bioavailability of 16-Bromoepiandrosterone can be decreased when combined with Magnesium carbonate.
19-norandrostenedioneThe bioavailability of 19-norandrostenedione can be decreased when combined with Magnesium carbonate.
2,5-Dimethoxy-4-ethylamphetamineMagnesium carbonate may decrease the excretion rate of 2,5-Dimethoxy-4-ethylamphetamine which could result in a higher serum level.
3,4-MethylenedioxyamphetamineMagnesium carbonate may decrease the excretion rate of 3,4-Methylenedioxyamphetamine which could result in a higher serum level.
3,4-MethylenedioxymethamphetamineMagnesium carbonate may decrease the excretion rate of 3,4-Methylenedioxymethamphetamine which could result in a higher serum level.
4-AndrostenedioneThe bioavailability of 4-Androstenedione can be decreased when combined with Magnesium carbonate.
4-Bromo-2,5-dimethoxyamphetamineMagnesium carbonate may decrease the excretion rate of 4-Bromo-2,5-dimethoxyamphetamine which could result in a higher serum level.
5-androstenedioneThe bioavailability of 5-androstenedione can be decreased when combined with Magnesium carbonate.
AcepromazineMagnesium carbonate can cause a decrease in the absorption of Acepromazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
AceprometazineMagnesium carbonate can cause a decrease in the absorption of Aceprometazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
AlclometasoneThe bioavailability of Alclometasone can be decreased when combined with Magnesium carbonate.
AldosteroneThe bioavailability of Aldosterone can be decreased when combined with Magnesium carbonate.
Alendronic acidThe serum concentration of Alendronic acid can be decreased when it is combined with Magnesium carbonate.
AlimemazineMagnesium carbonate can cause a decrease in the absorption of Alimemazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
AllopurinolMagnesium carbonate can cause a decrease in the absorption of Allopurinol resulting in a reduced serum concentration and potentially a decrease in efficacy.
AmcinonideThe bioavailability of Amcinonide can be decreased when combined with Magnesium carbonate.
AmphetamineMagnesium carbonate may decrease the excretion rate of Amphetamine which could result in a higher serum level.
AnecortaveThe bioavailability of Anecortave can be decreased when combined with Magnesium carbonate.
AtazanavirMagnesium carbonate can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
AtorvastatinThe serum concentration of Atorvastatin can be decreased when it is combined with Magnesium carbonate.
BeclomethasoneThe bioavailability of Beclomethasone can be decreased when combined with Magnesium carbonate.
Beclomethasone dipropionateThe bioavailability of Beclomethasone dipropionate can be decreased when combined with Magnesium carbonate.
BenzphetamineMagnesium carbonate may decrease the excretion rate of Benzphetamine which could result in a higher serum level.
BetamethasoneThe bioavailability of Betamethasone can be decreased when combined with Magnesium carbonate.
BisacodylThe therapeutic efficacy of Bisacodyl can be decreased when used in combination with Magnesium carbonate.
Bismuth SubcitrateThe therapeutic efficacy of Bismuth Subcitrate can be decreased when used in combination with Magnesium carbonate.
BL-1020Magnesium carbonate can cause a decrease in the absorption of BL-1020 resulting in a reduced serum concentration and potentially a decrease in efficacy.
BosutinibThe serum concentration of Bosutinib can be decreased when it is combined with Magnesium carbonate.
BudesonideThe bioavailability of Budesonide can be decreased when combined with Magnesium carbonate.
CaptoprilThe serum concentration of Captopril can be decreased when it is combined with Magnesium carbonate.
CefditorenThe serum concentration of Cefditoren can be decreased when it is combined with Magnesium carbonate.
CefpodoximeThe serum concentration of Cefpodoxime can be decreased when it is combined with Magnesium carbonate.
CefuroximeThe serum concentration of Cefuroxime can be decreased when it is combined with Magnesium carbonate.
CerivastatinThe serum concentration of Cerivastatin can be decreased when it is combined with Magnesium carbonate.
ChloroquineThe serum concentration of Chloroquine can be decreased when it is combined with Magnesium carbonate.
ChlorphentermineMagnesium carbonate may decrease the excretion rate of Chlorphentermine which could result in a higher serum level.
ChlorpromazineMagnesium carbonate can cause a decrease in the absorption of Chlorpromazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
ChlortetracyclineMagnesium carbonate can cause a decrease in the absorption of Chlortetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
CiclesonideThe bioavailability of Ciclesonide can be decreased when combined with Magnesium carbonate.
CinoxacinMagnesium carbonate can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
CiprofloxacinMagnesium carbonate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
ClobetasolThe bioavailability of Clobetasol can be decreased when combined with Magnesium carbonate.
Clobetasol propionateThe bioavailability of Clobetasol propionate can be decreased when combined with Magnesium carbonate.
ClocortoloneThe bioavailability of Clocortolone can be decreased when combined with Magnesium carbonate.
ClodronateThe serum concentration of Clodronate can be decreased when it is combined with Magnesium carbonate.
Coenzyme Q10The serum concentration of Coenzyme Q10 can be decreased when it is combined with Magnesium carbonate.
Cortisone acetateThe bioavailability of Cortisone acetate can be decreased when combined with Magnesium carbonate.
CysteamineThe therapeutic efficacy of Cysteamine can be decreased when used in combination with Magnesium carbonate.
Dabigatran etexilateThe serum concentration of Dabigatran etexilate can be decreased when it is combined with Magnesium carbonate.
DabrafenibThe serum concentration of Dabrafenib can be decreased when it is combined with Magnesium carbonate.
DasatinibMagnesium carbonate can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
DeferiproneThe serum concentration of Deferiprone can be decreased when it is combined with Magnesium carbonate.
dehydroepiandrosterone sulfateThe bioavailability of dehydroepiandrosterone sulfate can be decreased when combined with Magnesium carbonate.
DelavirdineThe serum concentration of Delavirdine can be decreased when it is combined with Magnesium carbonate.
DemeclocyclineMagnesium carbonate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
DesoximetasoneThe bioavailability of Desoximetasone can be decreased when combined with Magnesium carbonate.
Desoxycorticosterone acetateThe bioavailability of Desoxycorticosterone acetate can be decreased when combined with Magnesium carbonate.
Desoxycorticosterone PivalateThe bioavailability of Desoxycorticosterone Pivalate can be decreased when combined with Magnesium carbonate.
DexamethasoneThe bioavailability of Dexamethasone can be decreased when combined with Magnesium carbonate.
Dexamethasone isonicotinateThe bioavailability of Dexamethasone isonicotinate can be decreased when combined with Magnesium carbonate.
DexmethylphenidateMagnesium carbonate can cause an increase in the absorption of Dexmethylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
DextroamphetamineMagnesium carbonate may decrease the excretion rate of Dextroamphetamine which could result in a higher serum level.
DiethylpropionMagnesium carbonate may decrease the excretion rate of Diethylpropion which could result in a higher serum level.
DiflorasoneThe bioavailability of Diflorasone can be decreased when combined with Magnesium carbonate.
DifluocortoloneThe bioavailability of Difluocortolone can be decreased when combined with Magnesium carbonate.
DifluprednateThe bioavailability of Difluprednate can be decreased when combined with Magnesium carbonate.
Dipotassium phosphateMagnesium carbonate can cause a decrease in the absorption of Dipotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
DoxycyclineMagnesium carbonate can cause a decrease in the absorption of Doxycycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
ElvitegravirThe serum concentration of Elvitegravir can be decreased when it is combined with Magnesium carbonate.
EnoxacinMagnesium carbonate can cause a decrease in the absorption of Enoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
EquileninThe bioavailability of Equilenin can be decreased when combined with Magnesium carbonate.
EquilinThe bioavailability of Equilin can be decreased when combined with Magnesium carbonate.
ErlotinibThe serum concentration of Erlotinib can be decreased when it is combined with Magnesium carbonate.
EstroneThe bioavailability of Estrone can be decreased when combined with Magnesium carbonate.
Estrone sulfateThe bioavailability of Estrone sulfate can be decreased when combined with Magnesium carbonate.
Etidronic acidThe serum concentration of Etidronic acid can be decreased when it is combined with Magnesium carbonate.
Ferric CarboxymaltoseMagnesium carbonate can cause a decrease in the absorption of Ferric Carboxymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric CitrateMagnesium carbonate can cause a decrease in the absorption of Ferric Citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric pyrophosphateMagnesium carbonate can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
FexofenadineThe serum concentration of Fexofenadine can be decreased when it is combined with Magnesium carbonate.
FleroxacinMagnesium carbonate can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
fluasteroneThe bioavailability of fluasterone can be decreased when combined with Magnesium carbonate.
FludrocortisoneThe bioavailability of Fludrocortisone can be decreased when combined with Magnesium carbonate.
FlumequineMagnesium carbonate can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.
FlumethasoneThe bioavailability of Flumethasone can be decreased when combined with Magnesium carbonate.
FlunisolideThe bioavailability of Flunisolide can be decreased when combined with Magnesium carbonate.
Fluocinolone AcetonideThe bioavailability of Fluocinolone Acetonide can be decreased when combined with Magnesium carbonate.
FluocinonideThe bioavailability of Fluocinonide can be decreased when combined with Magnesium carbonate.
FluocortoloneThe bioavailability of Fluocortolone can be decreased when combined with Magnesium carbonate.
FluorometholoneThe bioavailability of Fluorometholone can be decreased when combined with Magnesium carbonate.
FluphenazineMagnesium carbonate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
FluprednideneThe bioavailability of Fluprednidene can be decreased when combined with Magnesium carbonate.
FluprednisoloneThe bioavailability of Fluprednisolone can be decreased when combined with Magnesium carbonate.
FlurandrenolideThe bioavailability of Flurandrenolide can be decreased when combined with Magnesium carbonate.
Fluticasone furoateThe bioavailability of Fluticasone furoate can be decreased when combined with Magnesium carbonate.
Fluticasone PropionateThe bioavailability of Fluticasone Propionate can be decreased when combined with Magnesium carbonate.
FluvastatinThe serum concentration of Fluvastatin can be decreased when it is combined with Magnesium carbonate.
FormestaneThe bioavailability of Formestane can be decreased when combined with Magnesium carbonate.
FosinoprilThe serum concentration of Fosinopril can be decreased when it is combined with Magnesium carbonate.
GabapentinThe serum concentration of Gabapentin can be decreased when it is combined with Magnesium carbonate.
GarenoxacinMagnesium carbonate can cause a decrease in the absorption of Garenoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
GatifloxacinMagnesium carbonate can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
GefitinibThe serum concentration of Gefitinib can be decreased when it is combined with Magnesium carbonate.
GemifloxacinMagnesium carbonate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
GrepafloxacinMagnesium carbonate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
HE3286The bioavailability of HE3286 can be decreased when combined with Magnesium carbonate.
HexamethylenetetramineThe therapeutic efficacy of Hexamethylenetetramine can be decreased when used in combination with Magnesium carbonate.
HydrocortisoneThe bioavailability of Hydrocortisone can be decreased when combined with Magnesium carbonate.
HydroxyamfetamineMagnesium carbonate may decrease the excretion rate of Hydroxyamphetamine hydrobromide which could result in a higher serum level.
HyoscyamineThe serum concentration of Hyoscyamine can be decreased when it is combined with Magnesium carbonate.
IbandronateThe serum concentration of Ibandronate can be decreased when it is combined with Magnesium carbonate.
IronMagnesium carbonate can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron DextranMagnesium carbonate can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron saccharateMagnesium carbonate can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
IsoniazidMagnesium carbonate can cause a decrease in the absorption of Isoniazid resulting in a reduced serum concentration and potentially a decrease in efficacy.
IstaroximeThe bioavailability of Istaroxime can be decreased when combined with Magnesium carbonate.
ItraconazoleThe serum concentration of Itraconazole can be decreased when it is combined with Magnesium carbonate.
KetoconazoleThe serum concentration of Ketoconazole can be decreased when it is combined with Magnesium carbonate.
LedipasvirThe serum concentration of Ledipasvir can be decreased when it is combined with Magnesium carbonate.
LevofloxacinMagnesium carbonate can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
LisdexamfetamineMagnesium carbonate may decrease the excretion rate of Lisdexamfetamine which could result in a higher serum level.
LomefloxacinMagnesium carbonate can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
LovastatinThe serum concentration of Lovastatin can be decreased when it is combined with Magnesium carbonate.
ME-609The bioavailability of ME-609 can be decreased when combined with Magnesium carbonate.
MecamylamineThe serum concentration of Mecamylamine can be increased when it is combined with Magnesium carbonate.
MedrysoneThe bioavailability of Medrysone can be decreased when combined with Magnesium carbonate.
MelengestrolThe bioavailability of Melengestrol can be decreased when combined with Magnesium carbonate.
MemantineThe serum concentration of Memantine can be increased when it is combined with Magnesium carbonate.
MephedroneMagnesium carbonate may decrease the excretion rate of Mephedrone which could result in a higher serum level.
MephentermineMagnesium carbonate may decrease the excretion rate of Mephentermine which could result in a higher serum level.
MesalazineThe therapeutic efficacy of Mesalazine can be decreased when used in combination with Magnesium carbonate.
MesoridazineMagnesium carbonate can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
MethamphetamineMagnesium carbonate may decrease the excretion rate of Methamphetamine which could result in a higher serum level.
MethotrimeprazineMagnesium carbonate can cause a decrease in the absorption of Methotrimeprazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methylene blueMagnesium carbonate can cause a decrease in the absorption of Methylene blue resulting in a reduced serum concentration and potentially a decrease in efficacy.
MethylphenidateMagnesium carbonate can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
MethylprednisoloneThe bioavailability of Methylprednisolone can be decreased when combined with Magnesium carbonate.
MevastatinThe serum concentration of Mevastatin can be decreased when it is combined with Magnesium carbonate.
MinocyclineMagnesium carbonate can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
MisoprostolThe risk or severity of adverse effects can be increased when Magnesium carbonate is combined with Misoprostol.
MMDAMagnesium carbonate may decrease the excretion rate of MMDA which could result in a higher serum level.
MometasoneThe bioavailability of Mometasone can be decreased when combined with Magnesium carbonate.
MoricizineMagnesium carbonate can cause a decrease in the absorption of Moricizine resulting in a reduced serum concentration and potentially a decrease in efficacy.
MoxifloxacinMagnesium carbonate can cause a decrease in the absorption of Moxifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Mycophenolic acidMagnesium carbonate can cause a decrease in the absorption of Mycophenolic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nalidixic AcidMagnesium carbonate can cause a decrease in the absorption of Nalidixic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
NCX 1022The bioavailability of NCX 1022 can be decreased when combined with Magnesium carbonate.
NemonoxacinMagnesium carbonate can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
NilotinibThe serum concentration of Nilotinib can be decreased when it is combined with Magnesium carbonate.
NorfloxacinMagnesium carbonate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
OfloxacinMagnesium carbonate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Oleoyl estroneThe bioavailability of Oleoyl estrone can be decreased when combined with Magnesium carbonate.
OxytetracyclineMagnesium carbonate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
PamidronateThe serum concentration of Pamidronate can be decreased when it is combined with Magnesium carbonate.
ParamethasoneThe bioavailability of Paramethasone can be decreased when combined with Magnesium carbonate.
PazopanibThe serum concentration of Pazopanib can be decreased when it is combined with Magnesium carbonate.
PazufloxacinMagnesium carbonate can cause a decrease in the absorption of Pazufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
PefloxacinMagnesium carbonate can cause a decrease in the absorption of Pefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
PenicillamineThe serum concentration of Penicillamine can be decreased when it is combined with Magnesium carbonate.
PerazineMagnesium carbonate can cause a decrease in the absorption of Perazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
PerphenazineMagnesium carbonate can cause a decrease in the absorption of Perphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
PhentermineMagnesium carbonate may decrease the excretion rate of Phentermine which could result in a higher serum level.
PitavastatinThe serum concentration of Pitavastatin can be decreased when it is combined with Magnesium carbonate.
Polystyrene sulfonateThe risk or severity of adverse effects can be increased when Magnesium carbonate is combined with Polystyrene sulfonate.
PrasteroneThe bioavailability of Prasterone can be decreased when combined with Magnesium carbonate.
PravastatinThe serum concentration of Pravastatin can be decreased when it is combined with Magnesium carbonate.
PrednicarbateThe bioavailability of Prednicarbate can be decreased when combined with Magnesium carbonate.
PrednisoloneThe bioavailability of Prednisolone can be decreased when combined with Magnesium carbonate.
PrednisoneThe bioavailability of Prednisone can be decreased when combined with Magnesium carbonate.
PregnenoloneThe bioavailability of Pregnenolone can be decreased when combined with Magnesium carbonate.
ProchlorperazineMagnesium carbonate can cause a decrease in the absorption of Prochlorperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
PromazineMagnesium carbonate can cause a decrease in the absorption of Promazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
PromethazineMagnesium carbonate can cause a decrease in the absorption of Promethazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
PropiopromazineMagnesium carbonate can cause a decrease in the absorption of Propiopromazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
PrulifloxacinMagnesium carbonate can cause a decrease in the absorption of Prulifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
PseudoephedrineMagnesium carbonate may decrease the excretion rate of Pseudoephedrine which could result in a higher serum level.
QuinidineMagnesium carbonate may decrease the excretion rate of Quinidine which could result in a higher serum level.
QuinineThe serum concentration of Quinine can be decreased when it is combined with Magnesium carbonate.
RilpivirineThe serum concentration of Rilpivirine can be decreased when it is combined with Magnesium carbonate.
RimexoloneThe bioavailability of Rimexolone can be decreased when combined with Magnesium carbonate.
RiociguatThe serum concentration of Riociguat can be decreased when it is combined with Magnesium carbonate.
RisedronateThe serum concentration of Risedronate can be decreased when it is combined with Magnesium carbonate.
RitobegronMagnesium carbonate may decrease the excretion rate of Ritobegron which could result in a higher serum level.
RosoxacinMagnesium carbonate can cause a decrease in the absorption of Rosoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
RosuvastatinThe serum concentration of Rosuvastatin can be decreased when it is combined with Magnesium carbonate.
SimvastatinThe serum concentration of Simvastatin can be decreased when it is combined with Magnesium carbonate.
Sodium glycerophosphateMagnesium carbonate can cause a decrease in the absorption of Sodium glycerophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium phosphatesMagnesium carbonate can cause a decrease in the absorption of Sodium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
SotalolThe serum concentration of Sotalol can be decreased when it is combined with Magnesium carbonate.
SparfloxacinMagnesium carbonate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
SulpirideThe serum concentration of Sulpiride can be decreased when it is combined with Magnesium carbonate.
Technetium tc 99m etidronateThe serum concentration of Technetium tc 99m etidronate can be decreased when it is combined with Magnesium carbonate.
Technetium Tc-99m MedronateThe serum concentration of Technetium Tc-99m Medronate can be decreased when it is combined with Magnesium carbonate.
TemafloxacinMagnesium carbonate can cause a decrease in the absorption of Temafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
TetracyclineMagnesium carbonate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
ThiethylperazineMagnesium carbonate can cause a decrease in the absorption of Thiethylperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
ThioridazineMagnesium carbonate can cause a decrease in the absorption of Thioridazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
TiludronateThe serum concentration of Tiludronate can be decreased when it is combined with Magnesium carbonate.
TixocortolThe bioavailability of Tixocortol can be decreased when combined with Magnesium carbonate.
TriamcinoloneThe bioavailability of Triamcinolone can be decreased when combined with Magnesium carbonate.
TriethylenetetramineMagnesium carbonate can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy.
TrifluoperazineMagnesium carbonate can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
TriflupromazineMagnesium carbonate can cause a decrease in the absorption of Triflupromazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
TrovafloxacinMagnesium carbonate can cause a decrease in the absorption of Trovafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zoledronic acidThe serum concentration of Zoledronic acid can be decreased when it is combined with Magnesium carbonate.
External LinksNot Available
ReferencesNot Available
Comments
comments powered by Disqus
Drug created on November 30, 2015 12:10 / Updated on August 17, 2016 12:24